Skip to main content

Table 2 Interventions

From: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial

 

Dexemedetomidine

Haloperidol

P

Time receiving study drug infusion while intubated, %: median (IQR)

100 (99.1 to 100.0)

94.26 (68.9 to 100.0)

0.2755

Loading dose given, %

80

60

0.329

Drug rate of infusion during the periods when it was administered: mean (95% CI)

0.47 (0.33 to 0.62) μg/kg/hour

1.43 (0.96 to 1.90) mg/hour

N/A

Study drug continued after extubation, %

70

40

0.18

Time study drug continued after extubation, hours: median (IQR)

2.5 (0.0 to 26.0)

0.0 (0.0 to 2.0)

0.15

Of patients who continued study drug after extubation, time continued, hours: median (IQR)

15 (1 to 26)

6.5 (2 to 16.5)

0.57

  1. CI = confidence interval; IQR = interquartile range.